Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Aberman Michael S
SVP Strategy Investor Relation at Regeneron Pharmaceuticals. Filing since 2 Sep 2011.
CIK 0001487767
Company
Date
Role
Action
Shares
Amount
Of holding
REGN
Regeneron Pharmaceuticals
22 Jun 2017
SVP Strategy Investor Relation
Sold, plan not stated
2,269
$1.21M
32.6%
REGN
Regeneron Pharmaceuticals
24 Mar 2015
SVP Strategy Investor Relation
Sold, plan not stated
4,843
$2.32M
27.9%
REGN
Regeneron Pharmaceuticals
18 Mar 2015
SVP Strategy Investor Relation
Sold, plan not stated
3,442
$1.60M
13.3%
REGN
Regeneron Pharmaceuticals
24 Feb 2015
SVP Strategy Investor Relation
Sold, plan not stated
3,374
$1.41M
15.4%
REGN
Regeneron Pharmaceuticals
17 Feb 2015
SVP Strategy Investor Relation
Sold, plan not stated
3,692
$1.49M
16.6%
REGN
Regeneron Pharmaceuticals
19 Aug 2014
VP Strategy and Investor Relat
Sold, plan not stated
3,611
$1.26M
18.8%
REGN
Regeneron Pharmaceuticals
18 Feb 2014
VP Strategy and Investor Relat
Sold, plan not stated
3,648
$1.21M
19.0%
REGN
Regeneron Pharmaceuticals
14 May 2013
VP Strategy and Investor Relat
Sold, plan not stated
5,529
$1.55M
32.1%
REGN
Regeneron Pharmaceuticals
6 May 2013
VP Strategy and Investor Relat
Sold, plan not stated
8,334
$2.14M
41.6%
REGN
Regeneron Pharmaceuticals
11 Dec 2012
VP Strategy and Investor Relat
Sold, plan not stated
3,368
$623.27K
24.3%
REGN
Regeneron Pharmaceuticals
30 Nov 2012
VP Strategy and Investor Relat
Sold, plan not stated
3,904
$705.23K
27.1%
REGN
Regeneron Pharmaceuticals
1 May 2012
VP Strategy and Investor Relat
Sold, plan not stated
6,162
$830.68K
38.1%
REGN
Regeneron Pharmaceuticals
7 Sep 2011
VP Strategy and Investor Relat
Sold, plan not stated
3,377
$235.26K
25.2%
REGN
Regeneron Pharmaceuticals
2 Sep 2011
VP Strategy and Investor Relat
Sold, plan not stated
4,166
$266.62K
29.4%
14 decisions on file.
